Independent predictors of breast malignancy in screen-detected microcalcifications: Biopsy results in 2545 cases

British Journal of Cancer

Volumn 105, Issue 11, 2011, Pages 1669-1675

  Farshid, G ^a   Sullivan, T ^b   Downey, P ^a   Gill, P G ^a   Pieterse, S ^a  

^a BreastScreen SA and SA Pathology   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

breast cancer; mammography; microcalcifications; screening

Indexed keywords

ADULT; AGED; ARTICLE; BREAST BIOPSY; BREAST CALCIFICATION; BREAST CANCER; BREAST HYPERPLASIA; CANCER GRADING; CANCER SCREENING; CANCER STAGING; CLINICAL FEATURE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; TUMOR LOCALIZATION; UNIVARIATE ANALYSIS;

BIOPSY; BREAST DISEASES; BREAST NEOPLASMS; CALCINOSIS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CARCINOMA, LOBULAR; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; EARLY DETECTION OF CANCER; FEMALE; HUMANS; HYPERPLASIA; MAMMOGRAPHY; MIDDLE AGED; MULTIVARIATE ANALYSIS; PRECANCEROUS CONDITIONS; RISK FACTORS;

EID: 81955161855     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2011.466     Document Type: Article

References (35)

1. Bent CK, Bassett LW, D'Orsi CJ, Sayre JW (2010) The positive predictive value of BI-RADS microcalcification descriptors and final assessment categories. Am J Roentgenol 194: 1378-1383
2. Betsill Jr WL, Rosen PP, Lieberman PH, Robbins GF (1978) Intraductal carcinoma. Long-term follow-up after treatment by biopsy alone. JAMA 239: 1863-1867 (Pubitemid 8322874)
3. BreastScreenAustralia (2005) BreastScreen Australia National Accreditation Handbook. Commonwealth of Australia: Canberra
4. Burnside ES, Ochsner JE, Fowler KJ, Fine JP, Salkowski LR, Rubin DL, Sisney GA (2007) Use of microcalcification descriptors in BI-RADS 4th edition to stratify risk of malignancy. Radiology 242: 388-395 (Pubitemid 46146191)
5. Burrell HC, Pinder SE, Wilson AR, Evans AJ, Yeoman LJ, Elston CW, Ellis IO (1996) The positive predictive value of mammographic signs: a review of 425 non-palpable breast lesions. Clin Radiol 51: 277-281
6. Castro NP, Osorio CA, Torres C, Bastos EP, Mourao-Neto M, Soares FA, Brentani HP, Carraro DM (2008) Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma. Breast Cancer Res 10: R87
7. Chagpar AB, McMasters KM, Sahoo S, Edwards MJ (2009) Does ductal carcinoma in situ accompanying invasive carcinoma affect prognosis? Surgery 146: 561-567; discussion 567-568
8. Dinkel HP, Gassel AM, Tschammler A (2000) Is the appearance of microcalcifications on mammography useful in predicting histological grade of malignancy in ductal cancer in situ? Br J Radiol 73: 938-944
9. Ernster VL, Ballard-Barbash R, Barlow WE, Zheng Y, Weaver DL, Cutter G, Yankaskas BC, Rosenberg R, Carney PA, Kerlikowske K, Taplin SH, Urban N, Geller BM (2002) Detection of ductal carcinoma in situ in women undergoing screening mammography. J Natl Cancer Inst 94: 1546-1554 (Pubitemid 35277278)
10. Evans AJ, Blanks RG (2002) Should breast screening programmes limit their detection of ductal carcinoma in situ? Clin Radiol 57: 1086-1089 (Pubitemid 35452745)
11. Farshid G, Rush G (2004) Assessment of 142 stellate lesions with imaging features suggestive of radial scar discovered during population-based screening for breast cancer. Am J Surg Pathol 28: 1626-1631 (Pubitemid 39564969)
12. Fisher ER, Dignam J, Tan-Chiu E, Costantino J, Fisher B, Paik S, Wolmark N (1999) Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of Protocol B-17: intraductal carcinoma. Cancer 86: 429-438 (Pubitemid 29347405)
13. Franceschi D, Crowe J, Zollinger R, Duchesneau R, Shenk R, Stefanek G, Shuck JM (1990) Breast biopsy for calcifications in nonpalpable breast lesions. A prospective study. Arch Surg 125: 170-173 (Pubitemid 20060640)
14. Gajdos C, Tartter PI, Bleiweiss IJ, Hermann G, de Csepel J, Estabrook A, Rademaker AW (2002) Mammographic appearance of nonpalpable breast cancer reflects pathologic characteristics. Ann Surg 235: 246-251 (Pubitemid 34111954)
15. Gulsun M, Demirkazik FB, Ariyurek M (2003) Evaluation of breast microcalcifications according to Breast Imaging Reporting and Data System criteria and Le Gal's classification. Eur J Radiol 47: 227-231 (Pubitemid 36970084)
16. Hermann G, Keller RJ, Drossman S, Caravella BA, Tartter P, Panetta RA, Bleiweiss IJ (1999) Mammographic pattern of microcalcifications in the preoperative diagnosis of comedo ductal carcinoma in situ: histopathologic correlation. Can Assoc Radiol J 50: 235-240 (Pubitemid 29465966)
17. Houghton J, George WD, Cuzick J, Dug gan C, Fentiman IS, Spittle M (2003) Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomised controlled trial. Lancet 362: 95-102 (Pubitemid 36831018)
18. Kerlikowske K, Barclay J, Grady D, Sickles EA, Ernster V (1997) Comparison of risk factors for ductal carcinoma in situ and invasive breast cancer. J Natl Cancer Inst 89: 76-82
19. Kerlikowske K, Molinaro A, Cha I, Ljung BM, Ernster VL, Stewart K, Chew K, Moore II DH, Waldman F (2003) Characteristics associated with recurrence among women with ductal carcinoma in situ treated by lumpectomy. J Natl Cancer Inst 95: 1692-1702 (Pubitemid 37509078)
20. Kuzmiak CM, Dancel R, Pisano E, Zeng D, Cole E, Koomen MA, McLelland R (2006) Consensus review: a method of assessment of calcifications that appropriately undergo a six-month follow-up. Acad Radiol 13: 621-629
21. Lazarus E, Mainiero MB, Schepps B, Koelliker SL, Livingston LS (2006) BI-RADS lexicon for US and mammography: interobserver variability and positive predictive value. Radiology 239: 385-391
22. Longnecker MP, Bernstein L, Paganini-Hill A, Enger SM, Ross RK (1996) Risk factors for in situ breast cancer. Cancer Epidemiol Biomarkers Prev 5: 961-965 (Pubitemid 26415867)
23. National Breast Cancer Centre (2002) Breast Imaging: A Guide for Practice. NBCC: Camperdown
24. National Breast Ovarian Cancer Centre (2010) Over Diagnosis from Mammography Screens. NBOCC Position Statement. NBOCC: Camperdown. http://canceraustralia.nbocc.org.au
25. Page DL, Dupont WD, Rogers LW, Jensen RA, Schuyler PA (1995) Continued local recurrence of carcinoma 15-25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy. Cancer 76: 1197-1200
26. Seo BK, Pisano ED, Kuzimak CM, Koomen M, Pavic D, Lee Y, Cole EB, Lee J (2006) Correlation of HER-2/neu overexpression with mammography and age distribution in primary breast carcinomas. Acad Radiol 13: 1211-1218 (Pubitemid 44363165)
27. Silverstein MJ, Buchanan C (2003) Ductal carcinoma in situ: USC/Van Nuys Prognostic Index and the impact of margin status. Breast 12: 457-471 (Pubitemid 38008660)
28. Silverstein MJ, Lagios MD (2010) Choosing treatment for patients with ductal carcinoma in situ: fine tuning the University of Southern California/Van Nuys Prognostic Index. J Natl Cancer Inst Monogr 2010: 193-196
29. Simpson PT, Reis-Filho JS, Gale T, Lakhani SR (2005) Molecular evolution of breast cancer. J Pathol 205: 248-254
30. Slanetz PJ, Giardino AA, Oyama T, Koerner FC, Halpern EF, Moore RH, Kopans DB (2001) Mammographic appearance of ductal carcinoma in situ does not reliably predict histologic subtype. Breast J 7: 417-421 (Pubitemid 34024465)
31. Stomper PC, Geradts J, Edge SB, Levine EG (2003) Mammographic predictors of the presence and size of invasive carcinomas associated with malignant microcalcification lesions without a mass. Am J Roentgenol 181: 1679-1684 (Pubitemid 37466553)
32. Stratton MR, Collins N, Lakhani SR, Sloane JP (1995) Loss of heterozygosity in ductal carcinoma in situ of the breast. J Pathol 175: 195-201
33. Trentham-Dietz A, Newcomb PA, Storer BE, Remington PL (2000) Risk factors for carcinoma in situ of the breast. Cancer Epidemiol Biomarkers Prev 9: 697-703 (Pubitemid 30482701)
34. Wiechmann L, Kuerer HM (2008) The molecular journey from ductal carcinoma in situ to invasive breast cancer. Cancer 112: 2130-2142 (Pubitemid 351628621)
35. Wohlfahrt J, Rank F, Kroman N, Melbye M (2004) A comparison of reproductive risk factors for CIS lesions and invasive breast cancer. Int J Cancer 108: 750-753 (Pubitemid 38076407)